A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors

Overview of attention for article published in Clinical Cancer Research, September 2009

Altmetric Badge

Mentioned by

patent: 2 patents

Readers on

mendeley: 42 Mendeley

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing…

Application US-8653093-B2

United States of America

Combination of pyrimidylaminobenzamide compounds and imatinib for treating…

Application US-7767688-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.